Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex32.htm |
| EX-31 - EXHIBIT 31 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex31.htm |
| EX-3.1 - EXHIBIT 3.1 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex3_1.htm |
| EX-10.118 - EXHIBIT 10.118 - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028ex10_118.htm |
| 10-Q - ORE PHARMACEUTICAL HOLDINGS INC. - ORE PHARMACEUTICAL HOLDINGS INC. | a6099028.htm |
Exhibit
10.92c
Summary of
2009 Incentive Compensation Plan
On August
13, 2009 the Compensation Committee (the "Committee") of the Board of Directors
of Ore Pharmaceuticals Inc. (the "Company") approved the Company's Incentive
Compensation Plan (the "Plan") for 2009. The Plan establishes
corporate and individual goals for eligible officers, including the current
Chief Financial Officer, but excluding in 2009 the Chief Executive Officer,
whose potential bonus is governed by terms in his employment
agreement. The Plan provides percentage weightings for each eligible
officer in three areas: corporate financial performance, corporate operational
performance and individual executive performance within such executive's areas
of responsibility. Subject to the discretion of the Committee as to
final amount, eligible officers may earn a bonus of up to 40% of their
respective salaries. In the case of officers serving less than a full
year in 2009, the bonus amounts will be prorated.
The
Committee intends to use the Plan as a guide to determine what level of bonus,
if any, will be paid to any of the eligible executives for their performance in
2009 based upon its judgment as to the level of achievement of each goal as of
year-end 2009.